Elaidic Acid Liposomal Phase Transition Management
Thermal Behavior of Elaidic Acid: Navigating the 42–44°C Phase Transition in Liposomal Extrusion
Elaidic acid, the trans-9-Octadecenoic Acid isomer of oleic acid, presents a distinct thermal profile that directly impacts liposomal manufacturing. Unlike its cis counterpart, the trans configuration yields a higher melting point and a sharp gel-to-liquid crystalline phase transition temperature (Tm) typically observed between 42°C and 44°C. This places elaidic acid firmly in the category of high-transition-temperature lipids, a classification that demands careful thermal management during extrusion. In practice, when using a mini-extruder or pilot-scale high-pressure homogenizer, the lipid must be maintained at least 10°C above its Tm to ensure complete fluidity and prevent filter blockage. At temperatures below 40°C, elaidic acid-rich membranes enter a gel phase, increasing rigidity and causing partial crystallization that can clog polycarbonate membranes. This behavior is well-documented in lipid research standard protocols, where aging of lipid films overnight at room temperature is explicitly discouraged for high-Tm lipids. For elaidic acid, even a brief drop to ambient conditions (22–25°C) can initiate gel-phase formation, leading to ill-defined vesicle concentrations and compromised batch reproducibility. Our field experience shows that a common pitfall is underestimating the cooling rate during transfer from a hot plate to the extruder; a pre-warmed syringe barrel and a jacketed extruder maintained at 55°C are essential to avoid localized solidification.
Beyond the primary Tm, a non-standard parameter worth noting is the viscosity shift near 35°C. While the bulk phase remains gel-like, we have observed a measurable decrease in dynamic viscosity that can be exploited for low-shear mixing without fully melting the lipid. This edge-case behavior is particularly relevant when co-formulating with cholesterol or pegylated lipids, where excessive heat may degrade sensitive components. For a deeper dive into analytical challenges posed by the trans isomer, see our article on resolving cis-trans isomer overlap in GC-MS lipidomics.
Impact of Temperature Drops on Vesicle Size Distribution and Drug Encapsulation Efficiency
Temperature excursions below the Tm of elaidic acid have a direct and often irreversible effect on liposome quality attributes. When a formulation containing trans-Oleic acid cools prematurely, the resulting gel-phase domains create membrane defects that lead to broad, multimodal vesicle size distributions. During extrusion, these rigid domains resist passage through 100 nm or 200 nm pores, causing a pressure buildup that can rupture the membrane or force aggregated lipid through, yielding vesicles with diameters far exceeding the nominal pore size. Dynamic light scattering (DLS) data from our applications lab consistently show a 30–50% increase in polydispersity index (PDI) when extrusion temperature falls below 50°C for elaidic acid-based liposomes. More critically, encapsulation efficiency of hydrophilic drugs drops sharply. The leaky interface between gel and liquid-crystalline phases allows passive diffusion of the aqueous cargo, reducing the final drug-to-lipid ratio. For hydrophobic drugs intercalated in the bilayer, phase separation can expel the active molecule, leading to crystal formation outside the vesicle. These effects are magnified in scale-up, where the thermal mass of larger vessels slows reheating and creates temperature gradients. A practical mitigation is to incorporate a 10–15% molar fraction of a fluidizing lipid such as DOPC, but this must be balanced against the desired rigidity and circulation half-life that elaidic acid provides. Our Japanese-language resource on GC-MS脂质オミクス用エライジン酸 further discusses isomer-specific analytical considerations that underpin formulation consistency.
Precision Thermal Ramping Protocols for Maintaining Fluidity Without Trans-Double Bond Degradation
Heating elaidic acid to its working temperature requires a balance between achieving full fluidity and avoiding thermal degradation of the trans double bond. Unlike polyunsaturated fatty acids, elaidic acid is relatively stable, but prolonged exposure above 80°C can induce isomerization back to the cis form or promote oxidation. Our recommended protocol involves a controlled ramp: from storage at -20°C, the bulk lipid or pre-formed film is brought to 25°C over 30 minutes, then heated to 55°C at a rate of 2°C/min under inert gas (argon or nitrogen). This gradual approach minimizes thermal shock and prevents localized overheating. For extrusion, the entire assembly—syringes, extruder block, and receiving vial—is pre-equilibrated at 55°C for at least 15 minutes. We have found that a circulating water bath is superior to a dry block heater for maintaining uniform temperature, as it eliminates cold spots at metal-to-plastic interfaces. Post-extrusion, the liposome suspension should be annealed at 55°C for 30 minutes to allow membrane reorganization before controlled cooling to storage temperature (typically 4°C). Rapid quenching on ice, while common for low-Tm lipids, can trap elaidic acid in a metastable gel phase with increased permeability. A field note: when working with (9E)-9-Octadecenoic acid at concentrations above 80 mol%, we have observed a slight yellowing of the lipid film if the ramping is done in ambient air, indicating trace oxidation. This does not typically affect phase behavior but can interfere with fluorescent assays; hence, inert atmosphere is strongly advised.
Bulk Packaging and COA Parameters: Ensuring Consistent Phase Transition Performance in Large-Scale Production
For procurement managers and formulation scientists sourcing elaidic acid at tonnage scale, lot-to-lot consistency in thermal behavior is paramount. NINGBO INNO PHARMCHEM CO.,LTD. supplies Elaidic Acid as a drop-in replacement for existing trans-fatty acid requirements, with a focus on cost-efficiency and supply chain reliability. Our standard industrial purity grade is ≥98% (GC), with the trans isomer content typically exceeding 95% of total C18:1 species. The certificate of analysis (COA) for each batch includes differential scanning calorimetry (DSC) data, reporting the onset temperature and peak maximum of the main endothermic transition. Please refer to the batch-specific COA for exact values, as minor variations in residual cis isomer or chain-length impurities can shift the Tm by ±1°C. The table below summarizes the key technical parameters that influence phase behavior in liposomal applications.
| Parameter | Specification | Impact on Phase Transition |
|---|---|---|
| Purity (GC) | ≥98% | Higher purity sharpens the transition peak |
| Trans isomer content | ≥95% of C18:1 | Lower trans content broadens Tm and lowers onset |
| Acid value (mg KOH/g) | 195–200 | Indicates free fatty acid integrity; degradation raises value |
| Peroxide value (meq/kg) | ≤5 | Oxidation products act as impurities, depressing Tm |
| Appearance at 25°C | White to off-white solid | Discoloration suggests oxidation or isomerization |
In terms of logistics, elaidic acid is typically packed in 25 kg net weight HDPE drums with inner aluminum foil laminate bags, purged with nitrogen to prevent oxidation during transit. For larger volumes, 210L steel drums or intermediate bulk containers (IBCs) are available. Storage at -20°C is recommended for long-term stability; however, the product can withstand short-term excursions up to 40°C during shipping without significant degradation, provided the packaging integrity is maintained. A practical consideration for bulk handling: at temperatures below 15°C, the solid lipid can become brittle and difficult to discharge from drums. Pre-warming the drum to 30–35°C in a temperature-controlled room for 24 hours before use restores a scoopable consistency without melting the material. This avoids the need for hot melt equipment at the point of use and minimizes thermal history. For comprehensive specifications and to discuss your specific formulation needs, visit our product page: high-purity elaidic acid for liposomal research and production.
Frequently Asked Questions
What is the optimal extrusion temperature for elaidic acid liposomes?
The optimal extrusion temperature is 55–60°C, which is approximately 10–15°C above the phase transition temperature (42–44°C). This ensures the lipid bilayer is fully in the liquid-crystalline phase, allowing smooth passage through polycarbonate membranes without clogging. Pre-warming all equipment is critical.
Can elaidic acid be mixed with phosphatidylcholine, and what ratios are recommended?
Yes, elaidic acid is commonly co-formulated with phosphatidylcholines such as DPPC or HSPC. Typical molar ratios range from 10:90 to 50:50 (elaidic acid:PC). Higher elaidic acid content increases membrane rigidity and Tm, which can be beneficial for sustained release but requires careful thermal management. Compatibility should be verified by DSC on the mixed film.
How should bulk 25 kg drums of elaidic acid be stored to prevent premature crystallization?
Drums should be stored upright in a freezer at -20°C ± 5°C. Before opening, allow the sealed drum to equilibrate to 25–30°C in a dry, inert atmosphere to prevent condensation. Once opened, the contents should be used promptly or re-purged with nitrogen and resealed. Avoid repeated freeze-thaw cycles, as these can introduce moisture and promote hydrolysis.
Does elaidic acid require any special handling due to its trans configuration?
While elaidic acid is chemically stable, the trans double bond is susceptible to isomerization under extreme conditions (prolonged heating above 80°C, strong UV light). Standard laboratory lighting and recommended processing temperatures do not pose a risk. Always handle under inert gas when heating above 60°C for extended periods.
What is the typical lead time for bulk orders of elaidic acid?
Lead times vary by quantity and destination. For 25 kg drum quantities from stock, shipment can typically be arranged within 5–7 business days. For tonnage orders, please contact our logistics team for current production schedules and availability.
Sourcing and Technical Support
As a global manufacturer of specialty chemicals, NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing elaidic acid with consistent phase transition performance, backed by rigorous COA documentation and responsive technical support. Whether you are scaling up a liposomal drug delivery platform or optimizing a lipidomics workflow, our team can assist with thermal protocol development and packaging solutions tailored to your process. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.